Search the Video Library

Filter by Date

Displaying Results 46 - 47 of 47

Dr. David Harpole, Duke University Medical Center, describes how he assists patients with the surgical decision-making process.

¿Cuáles son los riesgos y beneficios de ibrutinib y de idelalisib? ¿Cómo manejamos los efectos secundarios de los nuevos inhibidores de la tirosina cinasa?

GRACE sat down with Dr. Marco Ruiz to discuss "What are the risks and benefits of Ibrutinib and Idelalisib?" for our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments.